BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 88 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,056,000 | -72.6% | 1,080,000 | 0.0% | 0.46% | -65.5% |
| Q4 2015 | $11,146,000 | -9.5% | 1,080,000 | 0.0% | 1.33% | -32.2% |
| Q3 2015 | $12,312,000 | +21.3% | 1,080,000 | +58.8% | 1.97% | +45.6% |
| Q2 2015 | $10,152,000 | +65.3% | 680,000 | 0.0% | 1.35% | +42.3% |
| Q1 2015 | $6,140,000 | -36.9% | 680,000 | -15.0% | 0.95% | -36.7% |
| Q4 2014 | $9,728,000 | -9.6% | 800,000 | -27.3% | 1.50% | -32.2% |
| Q3 2014 | $10,758,000 | -27.8% | 1,100,000 | -5.8% | 2.21% | -43.9% |
| Q2 2014 | $14,892,000 | +20.5% | 1,168,000 | 0.0% | 3.95% | +38.9% |
| Q1 2014 | $12,357,000 | +506.6% | 1,168,000 | +335.8% | 2.84% | +380.7% |
| Q4 2013 | $2,037,000 | – | 268,000 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,744,356 | $18,455,000 | 9.59% |
| RA Capital Management | 4,347,456 | $45,996,000 | 3.30% |
| Cormorant Asset Management, LP | 1,168,000 | $12,357,000 | 2.84% |
| Baker Brothers Advisors | 5,867,031 | $62,073,000 | 0.79% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 907,920 | $9,606,000 | 0.39% |
| QVT Financial LP | 525,734 | $5,562,000 | 0.32% |
| EAM Investors, LLC | 114,548 | $1,212,000 | 0.22% |
| FRANKLIN STREET ADVISORS INC /NC | 93,000 | $984,000 | 0.20% |
| THB ASSET MANAGEMENT | 301,529 | $3,190,000 | 0.19% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,162,269 | $12,297,000 | 0.13% |